Abstract
Despite evidence from a variety of experimental approaches implicating the neuropeptide neurotensin in both the mechanism of action of antipsychotic drugs and the pathophysiology of schizophrenia, there has been some debate as to whether a peripherally administered neurotensin receptor agonist represents a sound strategy for the development of a novel class of antipsychotic drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 99-103 |
| Number of pages | 5 |
| Journal | Current Opinion in Pharmacology |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 1 2002 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Cellular and Molecular Neuroscience
- Pharmacology
Cite this
Neurotensin : An endogenous antipsychotic? Commentary. / Kinkead, Becky; Nemeroff, Charles.
In: Current Opinion in Pharmacology, Vol. 2, No. 1, 01.02.2002, p. 99-103.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Neurotensin
T2 - An endogenous antipsychotic? Commentary
AU - Kinkead, Becky
AU - Nemeroff, Charles
PY - 2002/2/1
Y1 - 2002/2/1
N2 - Despite evidence from a variety of experimental approaches implicating the neuropeptide neurotensin in both the mechanism of action of antipsychotic drugs and the pathophysiology of schizophrenia, there has been some debate as to whether a peripherally administered neurotensin receptor agonist represents a sound strategy for the development of a novel class of antipsychotic drugs.
AB - Despite evidence from a variety of experimental approaches implicating the neuropeptide neurotensin in both the mechanism of action of antipsychotic drugs and the pathophysiology of schizophrenia, there has been some debate as to whether a peripherally administered neurotensin receptor agonist represents a sound strategy for the development of a novel class of antipsychotic drugs.
UR - http://www.scopus.com/inward/record.url?scp=0036467316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036467316&partnerID=8YFLogxK
U2 - 10.1016/S1471-4892(01)00128-X
DO - 10.1016/S1471-4892(01)00128-X
M3 - Article
C2 - 11786316
AN - SCOPUS:0036467316
VL - 2
SP - 99
EP - 103
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
SN - 1471-4892
IS - 1
ER -